| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HANGER, INC. | SVP, Chief Clinical Officer | Common Stock | 0 | $18.75 | 03 Oct 2022 | Direct | |
| HANGER, INC. | SVP, Chief Clinical Officer | Stock Options (right to buy) | 0 | $5.98 | 03 Oct 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000156761922018170-campbell-james-h-2022-10-03 | HANGER, INC. | 03 Oct 2022 | 3 | -$1,145,753 | 4 | SVP, Chief Clinical Officer | 04 Oct 2022, 17:06 |
| /report/000156761922006800-campbell-james-h-2022-03-09 | HANGER, INC. | 09 Mar 2022 | 1 | -$24,974 | 4 | SVP, Chief Clinical Officer | 11 Mar 2022, 17:37 |
| /report/000156761922006739-campbell-james-h-2022-03-08 | HANGER, INC. | 08 Mar 2022 | 1 | -$34,589 | 4 | SVP, Chief Clinical Officer | 10 Mar 2022, 20:04 |
| /report/000156761922006588-campbell-james-h-2022-03-07 | HANGER, INC. | 07 Mar 2022 | 2 | -$78,082 | 4 | SVP, Chief Clinical Officer | 08 Mar 2022, 18:11 |
| /report/000156761922004763-campbell-james-h-2022-02-15 | HANGER, INC. | 15 Feb 2022 | 1 | $0 | 4 | SVP, Chief Clinical Officer | 16 Feb 2022, 17:07 |